Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund IDCW Direct |
[Equity: Thematic] |
|
|
|
|
Instruments Breakdown |
Instruments |
Composition |
Current Asset |
0.39 |
Equity |
71.22 |
Int Equity |
28.39 |
|
|
Concentration Analysis |
Top 5 Holdings |
40.42% |
Top 10 Holdings |
58.67% |
Top 25 Holdings |
85.05% |
|
|
|
|
Sector Analysis |
Sector/Ratings |
Net Asset(%) |
Pharma & Biotech |
54.11 |
Global Equity |
28.39 |
Healthcare |
17.11 |
Cash |
0.39 |
|
|
|
|
Portfolio Metrics |
|
PB Ratio |
110.95 |
PE Ratio |
852.15 |
|
|
Top 25 Holdings |
|
Holdings |
Net Asset(%) |
Sun Pharmaceutical Industries Limited |
13.16 |
Cipla Limited |
8.14 |
Dr Reddys Laboratories Limited |
7.49 |
Apollo Hospitals Enterprise Limited |
5.98 |
Max Healthcare Institute Limited |
5.65 |
DIVI LABORATORIES LTD |
5.29 |
ELI LILLY & CO |
3.94 |
JOHNSON & JOHNSON |
3.55 |
Lupin Limited |
2.77 |
Aurobindo Pharma Limited |
2.70 |
Merck & Co. Inc |
2.43 |
Torrent Pharmaceuticals Limited |
2.31 |
ABBVIE INC |
2.28 |
THERMO FISHER SCIENTIFIC INC |
1.89 |
Fortis Health Care Ltd |
1.85 |
NOVARTIS AG |
1.81 |
PFIZER INC |
1.76 |
Laurus Labs Limited |
1.73 |
Syngene International Limited |
1.72 |
DANAHER CORP |
1.62 |
ABBOTT LABORATORIES |
1.57 |
IPCA Laboratories Limited |
1.50 |
Biocon Limited |
1.34 |
Glenmark Pharmaceuticals Limited |
1.33 |
Gland Pharma Limited |
1.24 |
|
|
|
|
|
|
Sector Analysis Graphical Mode |
|
|
|
|
|
|
 |
|
|
|
|